FINANCIAL RELEASES

TEMPE, Ariz., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative

TEMPE, Ariz., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

Achieves 11 Millionth Invisalign Patient Milestone iTero Scanner Installed-base Reaches 50,000 Units Worldwide Q3 total revenues up 38.4% year-over-year to record $1.016 billion and up 0.5% sequentially Q3 diluted net income per share of $2.28; Q3 non-GAAP diluted net income per share of $2.87 Q3

TEMPE, Ariz., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

Q2 total revenues up 13.0% sequentially and 186.9% year-over-year to a record $1.0 billion Q2 diluted net income per share of $2.51; Q2 non-GAAP diluted net income per share of $3.04 Q2 operating margin of 26.6%, up 1.4 points sequentially and up 47.3 points year-over-year Q2 Clear Aligner revenues

TEMPE, Ariz., July 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., May 27, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative

TEMPE, Ariz., May 18, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., May 13, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

TEMPE, Ariz., May 06, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at

TEMPE, Ariz., May 03, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) today announced that it has entered into an accelerated stock repurchase agreement ("ASR") with Goldman Sachs & Co LLC, to repurchase $100 million of Align's common stock to complete its $600

Q1 total revenues up 7.2% sequentially and 62.4% year-over-year to a record $894.8 million Q1 diluted net income per share of $2.51; Q1 non-GAAP diluted net income per share of $2.49 Q1 operating income up 222.4% year-over-year to $225.4 million and operating margin of 25.2% Q1 Clear Aligner

Reflects Align’s continued investments in global operations to be closer to its doctor-customers and their patients, enhancing customer experience and satisfaction. Extends Align’s world class mass-customization capabilities which includes the world’s largest 3D printing operations, producing over

TEMPE, Ariz., April 01, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report first quarter 2021 financial results on Wednesday, April 28, 2021, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m.

Continued Strong Growth and Increasing Momentum for Invisalign Clear Aligners and iTero Systems and Services Across Products and Customer Channels Worldwide, Reflects the Strength of Align’s Doctor-Directed Model and the Align Digital Platform $99.7 million award includes the $54.2 million paid to

TEMPE, Ariz., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at an upcoming financial conference. The presentation, as noted below, will be webcast live via the Investor Relations section of Align Technology's website

Achieves 2 Millionth Invisalign Patient Milestone in EMEA Q4 total revenues up 13.7% sequentially and 28.4% year-over-year to a record $834.5 million Q4 diluted net income per share of $2.00, Q4 non-GAAP diluted net income per share of $2.61 Q4 operating margin of 25.5%, up 1.4 points sequentially